On May 27, H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Tourmaline Bio, Inc. (NASDAQ:TRML) while keeping the price target at $50. This comes after the company released promising results ...
TD Securities lowered the firm’s price target on Tourmaline Oil (TRMLF) to C$75 from C$77 and keeps a Buy rating on the shares. TipRanks is the most comprehensive data set of sell side analysts and ...
– Rapid, deep, and durable reductions in high-sensitivity C-reactive protein (hs-CRP) through Day 90 achieved across all pacibekitug arms with high statistical significance as compared to placebo (p<0 ...
Tourmaline Oil Corp has agreed to acquire Black Swan Energy, Calgary-based exploration and development company operating in the liquids-rich Montney region. The deal, expected to close in July, has a ...
Tourmaline Oil Corp. closed 13.2% short of its 52-week high of C$70.83, which the company achieved on February 21st.